BR0316823A - Uso de levocetirizina ou um sal desta farmaceuticamente aceitável - Google Patents

Uso de levocetirizina ou um sal desta farmaceuticamente aceitável

Info

Publication number
BR0316823A
BR0316823A BR0316823-9A BR0316823A BR0316823A BR 0316823 A BR0316823 A BR 0316823A BR 0316823 A BR0316823 A BR 0316823A BR 0316823 A BR0316823 A BR 0316823A
Authority
BR
Brazil
Prior art keywords
levocetirizine
pharmaceutically acceptable
acceptable salt
levocetirizin
treatment
Prior art date
Application number
BR0316823-9A
Other languages
English (en)
Inventor
Christophe Revirron
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32405747&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0316823(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of BR0316823A publication Critical patent/BR0316823A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ophthalmology & Optometry (AREA)

Abstract

"USO DE LEVOCETIRIZINA OU UM SAL DESTA FARMACEUTICAMENTE ACEITáVEL". A presente invenção diz respeito a um uso farmacêutico de levocetirizina para o tratamento de rinite alérgica persistente.
BR0316823-9A 2002-12-03 2003-05-26 Uso de levocetirizina ou um sal desta farmaceuticamente aceitável BR0316823A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02080064 2002-12-03
PCT/EP2003/005491 WO2004050094A1 (en) 2002-12-03 2003-05-26 Use of levocetirizine for the treatment of persistent allergic rhinitis

Publications (1)

Publication Number Publication Date
BR0316823A true BR0316823A (pt) 2005-10-18

Family

ID=32405747

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316823-9A BR0316823A (pt) 2002-12-03 2003-05-26 Uso de levocetirizina ou um sal desta farmaceuticamente aceitável

Country Status (26)

Country Link
US (1) US20060247258A1 (pt)
EP (1) EP1569650B1 (pt)
JP (1) JP2006509773A (pt)
KR (1) KR20050085298A (pt)
CN (1) CN1713912A (pt)
AT (1) ATE396730T1 (pt)
AU (1) AU2003238399B2 (pt)
BR (1) BR0316823A (pt)
CA (1) CA2506965A1 (pt)
CR (1) CR7835A (pt)
CY (1) CY1108191T1 (pt)
DE (1) DE60321377D1 (pt)
DK (1) DK1569650T3 (pt)
ES (1) ES2304514T3 (pt)
HR (1) HRP20050497B1 (pt)
MA (1) MA27530A1 (pt)
MX (1) MXPA05005795A (pt)
NO (1) NO20053247D0 (pt)
NZ (1) NZ540415A (pt)
PL (1) PL377470A1 (pt)
PT (1) PT1569650E (pt)
RU (1) RU2005121130A (pt)
SI (1) SI1569650T1 (pt)
TN (1) TNSN05154A1 (pt)
WO (1) WO2004050094A1 (pt)
ZA (1) ZA200503703B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060484A1 (es) 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10199031I2 (de) * 1992-09-24 2004-09-23 Sepracor Inc Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma.
US20030236275A1 (en) * 2002-06-20 2003-12-25 Schering Corporation Treatment methods of nasal congestion and nasal obstruction

Also Published As

Publication number Publication date
ZA200503703B (en) 2006-10-25
SI1569650T1 (sl) 2008-08-31
ES2304514T3 (es) 2008-10-16
AU2003238399B2 (en) 2009-05-07
CY1108191T1 (el) 2012-05-23
DE60321377D1 (de) 2008-07-10
PT1569650E (pt) 2008-06-26
MA27530A1 (fr) 2005-09-01
ATE396730T1 (de) 2008-06-15
KR20050085298A (ko) 2005-08-29
TNSN05154A1 (en) 2007-05-14
CR7835A (es) 2008-12-01
HRP20050497B1 (en) 2008-10-31
RU2005121130A (ru) 2005-12-10
EP1569650A1 (en) 2005-09-07
HRP20050497A2 (en) 2005-12-31
PL377470A1 (pl) 2006-02-06
DK1569650T3 (da) 2008-06-30
CA2506965A1 (en) 2004-06-17
NO20053247L (no) 2005-07-01
JP2006509773A (ja) 2006-03-23
US20060247258A1 (en) 2006-11-02
WO2004050094A1 (en) 2004-06-17
NZ540415A (en) 2008-06-30
NO20053247D0 (no) 2005-07-01
CN1713912A (zh) 2005-12-28
EP1569650B1 (en) 2008-05-28
MXPA05005795A (es) 2005-08-16
AU2003238399A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
BR0307050A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, sal farmaceuticamente aceitável, e, uso de um composto ou sal
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
BR0213358A (pt) Uso de flibanserina
DOP2002000429A (es) Imidazotriazinas
BR0110028A (pt) Uso de antagonistas-ngf para a prevenção ou tratamento de dor visceral crÈnica
PA8657201A1 (es) Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos
BR0314488A (pt) Composto, composição farmacêutica e métodos de tratamento
BR0308663A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção de doenças vasculares periféricas
BR0316206A (pt) Uso inibidores de histona desacetilase para o tratamento de distúrbios e de doenças oculares neovasculares ou edematosos
BRPI0410049A (pt) composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BRPI0412919A (pt) combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos
BR0111892A (pt) Bis-arilsulfonas
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
BR0113590A (pt) 7-oxo-piridopirimidinas
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BR0013793A (pt) Medicamentos profiláticos e terapêuticos para doenças oftálmicas
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
BRPI0408295A (pt) uso de um composto
BR0314843A (pt) Novo composto
BRPI0411347A (pt) combinações terapêuticas compreendendo inibidores de pde e antagonistas dos receptores de vasopressina para o tratamanento de dismenorréia
SE0002729D0 (sv) Novel compound form
BR0316823A (pt) Uso de levocetirizina ou um sal desta farmaceuticamente aceitável
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
BR0211358A (pt) Uso do composto de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-croman o e seus sais fisiologicamente aceitáveis

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI. A61K 31/495, A61P 11/00, A61P 37/00

Ipc: A61K 31/495 (2011.01), A61P 37/00 (2011.01), A61P

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.